Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results
01.11.2023 - Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced recent business highlights, including progress on its strategic transformation and a corresponding restructuring of operations and workforce reduction, and ...
Source: wallstreet-online.de